Journal
NATURE REVIEWS NEPHROLOGY
Volume 17, Issue 12, Pages 785-787Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41581-021-00491-7
Keywords
-
Categories
Ask authors/readers for more resources
Kidney transplant recipients, due to therapeutic immunosuppression, have impaired immune responses to the COVID-19 mRNA vaccine, necessitating a personalized intensified vaccination approach for better protection.
Kidney transplant recipients receive therapeutic immunosuppression that impairs their immune responses to the COVID-19 mRNA vaccine. For this reason, this vulnerable patient population is insufficiently protected by the standard two-dose COVID-19 vaccination programme and requires a specific follow-up to guide personalization of an intensified vaccination approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
